Pfizer Wins €1.9 Billion Court Order Against Poland, Romania Over Undelivered Covid Vaccines

A Belgian court has handed Pfizer a decisive legal victory, ordering Poland and Romania to pay the pharmaceutical giant a combined €1.9 billion for Covid-19 vaccine doses they refused to accept during the pandemic. This ruling represents a major enforcement of pandemic-era supply contracts, compelling two EU member states to fulfill financial obligations for products they ultimately did not take delivery of.

The case centers on contracts signed at the height of the global health crisis, when nations scrambled to secure vaccine supplies. As the pandemic's urgency waned and vaccination rates plateaued, some governments sought to renegotiate or cancel orders, leading to protracted disputes with manufacturers. The court's decision underscores the binding nature of these advance purchase agreements, rejecting the nations' refusal to accept the contracted doses and validating Pfizer's legal strategy to recoup the revenue.

The financial judgment places immediate budgetary pressure on Warsaw and Bucharest, requiring a significant payout to a major multinational corporation. Beyond the direct fiscal impact, the ruling sets a powerful precedent for the pharmaceutical industry, signaling that courts may enforce supply contracts even when government needs and public health circumstances evolve. It also highlights the complex and costly legacy of the pandemic's procurement scramble, where long-term financial liabilities now clash with shifted public health priorities.